Cargando…
miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5
MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667884/ https://www.ncbi.nlm.nih.gov/pubmed/31322243 http://dx.doi.org/10.3892/or.2019.7230 |
_version_ | 1783440117640200192 |
---|---|
author | Wang, Liping Chen, Weihong Zha, Jun Yan, Yongyong Wei, Yongxiang Chen, Xili Zhu, Xinxin Ge, Linhu |
author_facet | Wang, Liping Chen, Weihong Zha, Jun Yan, Yongyong Wei, Yongxiang Chen, Xili Zhu, Xinxin Ge, Linhu |
author_sort | Wang, Liping |
collection | PubMed |
description | MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally in a wide variety of cancers and has been associated with cellular proliferation, apoptosis, and invasion; however, the effect of miR-543 remains unknown in oral squamous cell carcinoma (OSCC). In the present study, the expression level of miR-543 in OSCC cell lines and tissues was investigated by RT-qPCR. A series of experiments was then performed to elucidate the functions of miR-543 in OSCC, such as CCK-8 assay, colony formation assay, flow cytometry, cell cycle distribution assay and cell apoptosis assay and Transwell assay. miR-543 expression was significantly upregulated in tumors from patients with OSCC and in OSCC cell lines. Overexpression of miR-543 promoted the proliferation, invasion and migration of OSCC cell lines, and inhibited cell apoptosis. In addition, the present study identified cytochrome P450 family 3 subfamily A member 5 (CYP3A5) as a direct target of miR-543 using software analysis and dual-luciferase reporter assays. In conclusion, the results of the present study suggest that miR-543 acts as a tumor promoter and serves a vital role in OSCC proliferation and invasion. These results confirm that miR-543 may serve as a potential novel target for the treatment of OSCC. |
format | Online Article Text |
id | pubmed-6667884 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-66678842019-08-08 miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 Wang, Liping Chen, Weihong Zha, Jun Yan, Yongyong Wei, Yongxiang Chen, Xili Zhu, Xinxin Ge, Linhu Oncol Rep Articles MicroRNAs (miRNAs/miRs) are small non-coding RNAs that can act as oncogenes or tumor-suppressor genes in human cancer. Previous studies have revealed that abnormal expression of miRNAs is closely associated with tumor cell cycle, differentiation, growth and apoptosis. miR-543 is expressed abnormally in a wide variety of cancers and has been associated with cellular proliferation, apoptosis, and invasion; however, the effect of miR-543 remains unknown in oral squamous cell carcinoma (OSCC). In the present study, the expression level of miR-543 in OSCC cell lines and tissues was investigated by RT-qPCR. A series of experiments was then performed to elucidate the functions of miR-543 in OSCC, such as CCK-8 assay, colony formation assay, flow cytometry, cell cycle distribution assay and cell apoptosis assay and Transwell assay. miR-543 expression was significantly upregulated in tumors from patients with OSCC and in OSCC cell lines. Overexpression of miR-543 promoted the proliferation, invasion and migration of OSCC cell lines, and inhibited cell apoptosis. In addition, the present study identified cytochrome P450 family 3 subfamily A member 5 (CYP3A5) as a direct target of miR-543 using software analysis and dual-luciferase reporter assays. In conclusion, the results of the present study suggest that miR-543 acts as a tumor promoter and serves a vital role in OSCC proliferation and invasion. These results confirm that miR-543 may serve as a potential novel target for the treatment of OSCC. D.A. Spandidos 2019-09 2019-07-11 /pmc/articles/PMC6667884/ /pubmed/31322243 http://dx.doi.org/10.3892/or.2019.7230 Text en Copyright: © Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Wang, Liping Chen, Weihong Zha, Jun Yan, Yongyong Wei, Yongxiang Chen, Xili Zhu, Xinxin Ge, Linhu miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
title | miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
title_full | miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
title_fullStr | miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
title_full_unstemmed | miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
title_short | miR-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting CYP3A5 |
title_sort | mir-543 acts as a novel oncogene in oral squamous cell carcinoma by targeting cyp3a5 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667884/ https://www.ncbi.nlm.nih.gov/pubmed/31322243 http://dx.doi.org/10.3892/or.2019.7230 |
work_keys_str_mv | AT wangliping mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT chenweihong mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT zhajun mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT yanyongyong mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT weiyongxiang mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT chenxili mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT zhuxinxin mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 AT gelinhu mir543actsasanoveloncogeneinoralsquamouscellcarcinomabytargetingcyp3a5 |